Alignment Healthcare, Inc.

Alignment Healthcare, Inc. (ALHC)

$5.87

+0.14

(+2.44%)

Market is closed - opens 7 PM, 01 Jun 2023

Insights on Alignment Healthcare, Inc.

  • Increasing Revenue

    Revenue is up for the last 3 quarters, 360.34M → 439.15M (in $), with an average increase of 9.0% per quarter

  • Increasing Net Profit

    Netprofit is up for the last 2 quarters, -56.90M → -37.28M (in $), with an average increase of 52.6% per quarter

  • Vs HUM

    In the last 1 year, Humana Inc. has given 9.0% return, outperforming this stock by 55.3%

Performance

  • $5.50
    $5.89
    $5.87
    downward going graph

    6.3%

    Downside

    Day's Volatility :6.62%

    Upside

    0.34%

    downward going graph
  • $4.88
    $19.17
    $5.87
    downward going graph

    16.87%

    Downside

    52 Weeks Volatility :74.54%

    Upside

    69.38%

    downward going graph

Returns

PeriodAlignment Healthcare, Inc. Sector (Health Care)Index (Russel 2000)
3 Months
-42.35%
-0.3%
-6.7%
6 Months
-56.92%
-8.8%
-6.2%
1 Year
-46.35%
-4.2%
-5.1%
3 Years
-66.9%
23.0%
26.9%

Highlights

Market Capitalization
1.1B
Book Value
$1.18
Dividend Share
0.0
Dividend Yield
0.0%
Earnings Per Share (EPS)
-0.76
Wall Street Target Price
11.44
Profit Margin
-9.56%
Operating Margin TTM
-8.16%
Return On Assets TTM
-11.06%
Return On Equity TTM
-56.53%
Revenue TTM
1.5B
Revenue Per Share TTM
8.38
Quarterly Revenue Growth YOY
27.1%
Gross Profit TTM
184.3M
EBITDA
-106.2M
Diluted Eps TTM
-0.76
Quarterly Earnings Growth YOY
0.0
EPS Estimate Current Year
-0.79
EPS Estimate Next Year
-0.67
EPS Estimate Current Quarter
-0.25
EPS Estimate Next Quarter
-0.1

Analyst Recommendation

Buy
    75%Buy
    25%Hold
    0
    0%Sell
Based on 16 Wall street analysts offering stock ratings for Alignment Healthcare, Inc. (by analysts ranked 0 to 5 stars)
Based on 16 analyst
  • Current
  • 1M Ago
  • 3M Ago
Buy
12
12
13
Hold
4
4
3
Sell
00
00
00

Analyst Forecast

What analysts predicted

Upside of 94.89%

Current $5.87
Target $11.44

Company Financials

FY19Y/Y Change
Revenue
757.0M
-
Net Income
-44.7M
-
Net Profit Margin
-5.91%
-
FY20Y/Y Change
Revenue
959.2M
↑ 26.72%
Net Income
-22.9M
↓ 48.75%
Net Profit Margin
-2.39%
↑ 3.52%
FY21Y/Y Change
Revenue
1.2B
↑ 21.74%
Net Income
-195.3M
↑ 751.81%
Net Profit Margin
-16.72%
↓ 14.33%
FY22Y/Y Change
Revenue
1.4B
↑ 22.81%
Net Income
-149.5M
↓ 23.42%
Net Profit Margin
-10.43%
↑ 6.29%
Q4 FY21Q/Q Change
Revenue
298.3M
↑ 1.64%
Net Income
-47.8M
↑ 4.4%
Net Profit Margin
-16.04%
↓ 0.43%
Q1 FY22Q/Q Change
Revenue
345.5M
↑ 15.84%
Net Income
-40.8M
↓ 14.67%
Net Profit Margin
-11.81%
↑ 4.23%
Q2 FY22Q/Q Change
Revenue
366.5M
↑ 6.06%
Net Income
-11.6M
↓ 71.63%
Net Profit Margin
-3.16%
↑ 8.65%
Q3 FY22Q/Q Change
Revenue
360.3M
↓ 1.67%
Net Income
-40.2M
↑ 247.56%
Net Profit Margin
-11.17%
↓ 8.01%
Q4 FY22Q/Q Change
Revenue
361.8M
↑ 0.41%
Net Income
-56.9M
↑ 41.38%
Net Profit Margin
-15.73%
↓ 4.56%
Q1 FY23Q/Q Change
Revenue
439.2M
↑ 21.38%
Net Income
-37.3M
↓ 34.48%
Net Profit Margin
-8.49%
↑ 7.24%
FY19Y/Y Change
Total Assets
193.4M
-
Total Liabilities
272.2M
-
FY20Y/Y Change
Total Assets
338.5M
↑ 74.99%
Total Liabilities
307.9M
↑ 13.13%
FY21Y/Y Change
Total Assets
630.9M
↑ 86.38%
Total Liabilities
324.8M
↑ 5.5%
FY22Y/Y Change
Total Assets
633.9M
↑ 0.47%
Total Liabilities
394.6M
↑ 21.46%
Q4 FY21Q/Q Change
Total Assets
630.9M
↓ 3.96%
Total Liabilities
324.8M
↓ 2.11%
Q1 FY22Q/Q Change
Total Assets
646.6M
↑ 2.49%
Total Liabilities
353.3M
↑ 8.77%
Q2 FY22Q/Q Change
Total Assets
666.8M
↑ 3.12%
Total Liabilities
373.1M
↑ 5.59%
Q3 FY22Q/Q Change
Total Assets
777.5M
↑ 16.61%
Total Liabilities
505.4M
↑ 35.47%
Q4 FY22Q/Q Change
Total Assets
633.9M
↓ 18.48%
Total Liabilities
394.6M
↓ 21.93%
Q1 FY23Q/Q Change
Total Assets
761.8M
↑ 20.18%
Total Liabilities
537.8M
↑ 36.31%
FY19Y/Y Change
Operating Cash Flow
9.2M
-
Investing Cash Flow
-10.2M
-
Financing Cash Flow
52.7M
-
FY20Y/Y Change
Operating Cash Flow
7.6M
↓ 17.89%
Investing Cash Flow
-16.4M
↑ 59.75%
Financing Cash Flow
130.1M
↑ 147.08%
FY21Y/Y Change
Operating Cash Flow
-78.8M
↓ 1141.87%
Investing Cash Flow
-20.8M
↑ 27.25%
Financing Cash Flow
360.1M
↑ 176.76%
Q4 FY21Q/Q Change
Operating Cash Flow
-56.2M
↓ 534.98%
Investing Cash Flow
-3.0M
↓ 57.82%
Financing Cash Flow
-100.0K
↑ 0.0%
Q1 FY22Q/Q Change
Operating Cash Flow
-11.6M
↓ 79.28%
Investing Cash Flow
-6.1M
↑ 107.62%
Financing Cash Flow
-100.0K
↑ 0.0%
Q2 FY22Q/Q Change
Operating Cash Flow
10.4M
↓ 188.97%
Investing Cash Flow
-5.9M
↓ 4.44%
Financing Cash Flow
-100.0K
↑ 0.0%
Q3 FY22Q/Q Change
Operating Cash Flow
105.1M
↑ 915.26%
Investing Cash Flow
-8.1M
↑ 38.82%
Financing Cash Flow
17.2M
↓ 17320.0%
Q1 FY23Q/Q Change
Operating Cash Flow
85.1M
↓ 157.02%
Investing Cash Flow
-110.4M
-
Financing Cash Flow
30.0K
↓ 105.69%

Technicals Summary

Sell

Neutral

Buy

Alignment Healthcare, Inc. is currently not in a favorable trading position ( SELL ) according to technical analysis indicators.

Peers

Company Name1 Month6 Month1 Year3 Years5 Years
Alignment Healthcare, Inc.
Alignment Healthcare, Inc.
-16.35%
-56.92%
-46.35%
-66.9%
-66.9%
Cigna Corp.
Cigna Corp.
-4.81%
-26.22%
-9.56%
22.48%
43.26%
UnitedHealth Group Incorporated
UnitedHealth Group Incorporated
-3.2%
-12.4%
-3.41%
56.85%
98.69%
CVS Health Corporation
CVS Health Corporation
-9.12%
-34.09%
-30.59%
2.3%
5.93%
Humana Inc.
Humana Inc.
-7.48%
-9.97%
9.0%
23.31%
70.15%
  Elevance Health, Inc
Elevance Health, Inc
-6.47%
-17.11%
-6.63%
-6.63%
-6.63%
Company NameP/E RatioP/B RatioPEG RatioEPSROEROADiv YieldBVPS
Alignment Healthcare, Inc.
Alignment Healthcare, Inc.
NA
NA
NA
-0.79
-0.57
-0.11
0.0
1.18
Cigna Corp.
Cigna Corp.
11.2
11.2
1.22
24.69
0.15
0.03
0.02
150.19
UnitedHealth Group Incorporated
UnitedHealth Group Incorporated
22.03
22.03
1.66
24.99
0.25
0.07
0.01
87.25
CVS Health Corporation
CVS Health Corporation
22.47
22.47
1.36
8.61
0.05
0.04
0.04
55.81
Humana Inc.
Humana Inc.
20.12
20.12
1.28
28.36
0.19
0.06
0.01
132.67
  Elevance Health, Inc
Elevance Health, Inc
17.06
17.06
1.38
32.85
0.17
0.05
0.01
157.54
Company NameAnalyst ViewMarket Cap5 Years Return %PE RatioProfit Margin
Alignment Healthcare, Inc.
Alignment Healthcare, Inc.
Buy
$1.1B
-66.9%
NA
-9.56%
Cigna Corp.
Cigna Corp.
Buy
$72.2B
43.26%
11.2
3.69%
UnitedHealth Group Incorporated
UnitedHealth Group Incorporated
Buy
$448.3B
98.69%
22.03
6.16%
CVS Health Corporation
CVS Health Corporation
Buy
$86.7B
5.93%
22.47
1.19%
Humana Inc.
Humana Inc.
Buy
$62.0B
70.15%
20.12
3.26%
  Elevance Health, Inc
Elevance Health, Inc
Buy
$104.2B
-6.63%
17.06
3.87%

Institutional Holdings

  • General Atlantic Llc

    32.38%
  • Warburg Pincus LLC

    9.51%
  • FMR Inc

    8.94%
  • T. Rowe Price Investment Management,Inc.

    5.65%
  • Vanguard Group Inc

    4.39%
  • BlackRock Inc

    3.57%

Corporate Announcements

  • Alignment Healthcare, Inc. Earnings

    Alignment Healthcare, Inc. ’s price-to-earnings ratio stands at None

    Read More

Company Information

Alignment Healthcare is a consumer-centric platform delivering customized health care in the United States to seniors and those who need it most, the chronically ill and frail, through its Medicare Advantage plans. Alignment Healthcare provides partners and patients with customized care and service where they need it and when they need it, including clinical coordination, risk management and technology facilitation. Alignment Healthcare offers health plan options through Alignment Health Plan, and also partners with select health plans to help deliver better benefits at lower costs.

Organization
Alignment Healthcare, Inc.
Employees
1037
CEO
Mr. John E. Kao
Industry
Healthcare

FAQs